20
Participants
Start Date
December 28, 2012
Primary Completion Date
January 23, 2019
Study Completion Date
January 23, 2019
CC-292
CC-292-will be given twice daily on Days 8-28 of Cycle 1 and on Days 1-28 of the remaining 28-day cycles.
Lenalidomide
Lenalidomde will be given once daily on Days 1-28 of 28-day cycles.
Allgemeines Krankenhaus Wien, Vienna
Medizinische Abteilung-Zentrum fur Onkologie und Hamatologie, Vienna
AKh Linz, Linz
Universitatsklinik der PMU, Salzburg
Mount Sinai School of Medicine, New York
Clearview Cancer Institute Oncology Specialties, P.C, Huntsville
The West Clinic, Memphis
Horizon Oncology Center, Lafayette
MD Anderson Cancer Center, Houston
Hackensack University Medical Center, Hackensack
Universitatsklinik fur Innere Medizin, Innsbruck
Lead Sponsor
Celgene
INDUSTRY